RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.
2012-01-01 Mesiano G; Todorovic M; Gammaitoni L; Leuci V; Giraudo Diego L; Carnevale-Schianca F; Fagioli F; Piacibello W; Aglietta M; Sangiolo D.
Cytokine-induced killer cells as immunotherapy for solid tumors: current evidences and perspectives
2015-01-01 Giraudo, Lidia; Gammaitoni, Loretta; Cangemi, Michela; Rotolo, Ramona; Aglietta, Massimo; Sangiolo, Dario
Duration of trastuzumab for HER2-positive breast cancer.
2013-01-01 Montemurro F;Aglietta M
Emerging molecular target antagonists for the treatment of biliary tract cancer
2018-01-01 Lombardi, Pasquale; Marino, Donatella*; Fenocchio, Elisabetta; Chilà, Giovanna; Aglietta, Massimo; Leone, Francesco
Endometrial Cancer Stem Cells: Role, Characterization and Therapeutic Implications
2019-01-01 Giannone, Gaia; Attademo, Laura; Scotto, Giulia; Genta, Sofia; Ghisoni, Eleonora; Tuninetti, Valentina; Aglietta, Massimo; Pignata, Sandro; Valabrega, Giorgio
Ex Vivo-Activated MHC-Unrestricted Immune Effectors for Cancer Adoptive Immunotherapy
2014-01-01 Leuci V; Mesiano G; Gammaitoni L; Todorovic M; Giraudo L; Fabrizio CS; Aglietta M; Sangiolo D.
Fluoropyrimidine-induced cardiotoxicity
2018-01-01 Depetris, Ilaria; Marino, Donatella; Bonzano, Alessandro; Cagnazzo, Celeste; Filippi, Roberto; Aglietta, Massimo; Leone, Francesco
Gene-modified T lymphocytes in the setting of hematopoietic cell transplantation: potential benefits and possible risks.
2011-01-01 Sangiolo D; Leuci V; Gallo S; Aglietta M; Piacibello W.
Genetically Redirected T Lymphocytes for Adoptive Immunotherapy of Solid Tumors.
2014-01-01 Leuci V; Mesiano G; Gammaitoni L; Aglietta M; Sangiolo D.
Hitting multiple targets in HER2-positive breast cancer: proof of principle or therapeutic opportunity?
2011-01-01 Geuna E; Milani A; Redana S; Rossi V; Valabrega G; Aglietta M; Montemurro F.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors. | 2012 | Mesiano G; Todorovic M; Gammaitoni L; Leuci V; Giraudo Diego L; Carnevale-Schianca F; Fagioli F; Piacibello W; Aglietta M; Sangiolo D. | |
Cytokine-induced killer cells as immunotherapy for solid tumors: current evidences and perspectives | 2015 | Giraudo, Lidia; Gammaitoni, Loretta; Cangemi, Michela; Rotolo, Ramona; Aglietta, Massimo; Sangiolo, Dario | |
Duration of trastuzumab for HER2-positive breast cancer. | 2013 | Montemurro F;Aglietta M | |
Emerging molecular target antagonists for the treatment of biliary tract cancer | 2018 | Lombardi, Pasquale; Marino, Donatella*; Fenocchio, Elisabetta; Chilà, Giovanna; Aglietta, Massimo; Leone, Francesco | |
Endometrial Cancer Stem Cells: Role, Characterization and Therapeutic Implications | 2019 | Giannone, Gaia; Attademo, Laura; Scotto, Giulia; Genta, Sofia; Ghisoni, Eleonora; Tuninetti, Valentina; Aglietta, Massimo; Pignata, Sandro; Valabrega, Giorgio | |
Ex Vivo-Activated MHC-Unrestricted Immune Effectors for Cancer Adoptive Immunotherapy | 2014 | Leuci V; Mesiano G; Gammaitoni L; Todorovic M; Giraudo L; Fabrizio CS; Aglietta M; Sangiolo D. | |
Fluoropyrimidine-induced cardiotoxicity | 2018 | Depetris, Ilaria; Marino, Donatella; Bonzano, Alessandro; Cagnazzo, Celeste; Filippi, Roberto; Aglietta, Massimo; Leone, Francesco | |
Gene-modified T lymphocytes in the setting of hematopoietic cell transplantation: potential benefits and possible risks. | 2011 | Sangiolo D; Leuci V; Gallo S; Aglietta M; Piacibello W. | |
Genetically Redirected T Lymphocytes for Adoptive Immunotherapy of Solid Tumors. | 2014 | Leuci V; Mesiano G; Gammaitoni L; Aglietta M; Sangiolo D. | |
Hitting multiple targets in HER2-positive breast cancer: proof of principle or therapeutic opportunity? | 2011 | Geuna E; Milani A; Redana S; Rossi V; Valabrega G; Aglietta M; Montemurro F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 03-CONTRIBUTO IN RIVISTA 50
- 03-CONTRIBUTO IN RIVISTA::03B-Rev... 50
Data di pubblicazione
- 2020 - 2021 4
- 2010 - 2019 41
- 2008 - 2009 5
Rivista
- EXPERT OPINION ON BIOLOGICAL THERAPY 7
- CRITICAL REVIEWS IN ONCOLOGY HEMA... 5
- BREAST CANCER 3
- CANCERS 3
- EXPERT OPINION ON PHARMACOTHERAPY 3
- THE LANCET ONCOLOGY 2
- THE NEW ENGLAND JOURNAL OF MEDICINE 2
- ADVANCES IN THERAPY 1
- ANNALS OF ONCOLOGY 1
- ANNALS OF TRANSLATIONAL MEDICINE 1
Keyword
- breast cancer 7
- immunotherapy 7
- adoptive immunotherapy 5
- HER2 4
- cholangiocarcinoma 3
- CIK 3
- NK 3
- Oncology 3
- sarcomas 3
- solid tumors 3
Lingua
- eng 50
Accesso al fulltext
- reserved 27
- open 15
- partially open 6
- no fulltext 2